ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE)

ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE) was reported 103 times

These side effects are most commonly reported by patients taking ACETAMINOPHEN CAPSULES 500MG (MINIS-RED OPAQUE):

# Side effect Count
0 DRUG INEFFECTIVE 11
1 CONSTIPATION 8
2 DIARRHOEA 8
3 FATIGUE 8
4 PRODUCT DOSE OMISSION ISSUE 7
5 HEADACHE 6
6 MALAISE 6
7 OFF LABEL USE 6
8 ARTHRALGIA 5
9 NAUSEA 5
10 PAIN 5
11 URINARY TRACT INFECTION 5
12 VOMITING 5
13 COUGH 4
14 GAIT DISTURBANCE 4
15 MOBILITY DECREASED 4
16 MUSCULOSKELETAL STIFFNESS 4
17 MYALGIA 4
18 PAIN IN EXTREMITY 4
19 PNEUMONIA 4
20 WEIGHT DECREASED 4
21 ALOPECIA 3
22 ASTHENIA 3
23 BACK PAIN 3
24 BALANCE DISORDER 3
25 CONDITION AGGRAVATED 3
26 COVID-19 3
27 DIZZINESS 3
28 DYSPNOEA 3
29 PRODUCT QUALITY ISSUE 3
30 RASH 3
31 SOMNOLENCE 3
32 ABDOMINAL PAIN 2
33 ANAEMIA 2
34 BLOOD URINE PRESENT 2
35 CENTRAL NERVOUS SYSTEM LESION 2
36 CHEST PAIN 2
37 CROHN^S DISEASE 2
38 CYSTITIS 2
39 DEATH 2
40 DECREASED APPETITE 2
41 DEHYDRATION 2
42 DEPRESSION 2
43 DISCOMFORT 2
44 DRUG ABUSE 2
45 DRUG HYPERSENSITIVITY 2
46 DRY EYE 2
47 FALL 2
48 FEELING ABNORMAL 2
49 GASTRIC DISORDER 2
50 HOT FLUSH 2
51 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
52 INFECTION 2
53 INJECTION SITE HAEMATOMA 2
54 INSOMNIA 2
55 MEMORY IMPAIRMENT 2
56 MIGRAINE 2
57 MOVEMENT DISORDER 2
58 MUSCULAR WEAKNESS 2
59 MYOCARDIAL INFARCTION 2
60 PHOTOPHOBIA 2
61 PRODUCT ADHESION ISSUE 2
62 PRURITUS 2
63 RHEUMATIC FEVER 2
64 SINUS DISORDER 2
65 SKIN EXFOLIATION 2
66 SLEEP DISORDER 2
67 SURGERY 2
68 URINARY TRACT DISORDER 2
69 VISION BLURRED 2
70 ABASIA 1
71 ABDOMINAL DISCOMFORT 1
72 ACCIDENT 1
73 ACCIDENTAL OVERDOSE 1
74 ACNE 1
75 ADVERSE EVENT 1
76 AGEUSIA 1
77 AMNESIA 1
78 ANGIOEDEMA 1
79 ANOSMIA 1
80 ANTICOAGULANT THERAPY 1
81 ARRHYTHMIA 1
82 ARTHRITIS 1
83 ARTHROSCOPY 1
84 ASCITES 1
85 ATRIAL FIBRILLATION 1
86 BLADDER CANCER 1
87 BLADDER DISORDER 1
88 BLINDNESS 1
89 BLOOD BILIRUBIN DECREASED 1
90 BLOOD GLUCOSE DECREASED 1
91 BLOOD IRON DECREASED 1
92 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1
93 BLOOD POTASSIUM DECREASED 1
94 BLOODY DISCHARGE 1
95 BONE CONTUSION 1
96 BONE PAIN 1
97 BRONCHITIS 1
98 CARDIAC FAILURE 1
99 CARDIO-RESPIRATORY ARREST 1
100 CELLULITIS 1
101 CEREBRAL INFARCTION 1
102 COGNITIVE DISORDER 1
103 CONFUSIONAL STATE 1
104 DEVICE DEFECTIVE 1
105 DEVICE MALFUNCTION 1
106 DISORIENTATION 1
107 DRUG DOSE OMISSION 1
108 DRUG EFFECT DECREASED 1
109 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
110 DRUG INTERACTION 1
111 DYSURIA 1
112 EPISTAXIS 1
113 ERYTHEMA 1
114 EXTRA DOSE ADMINISTERED 1
115 FAECES DISCOLOURED 1
116 FAECES HARD 1
117 FAILURE TO THRIVE 1
118 FEEDING DISORDER 1
119 FLATULENCE 1
120 FOOT FRACTURE 1
121 FUNCTIONAL GASTROINTESTINAL DISORDER 1
122 GENERAL PHYSICAL HEALTH DETERIORATION 1
123 GENERAL SYMPTOM 1
124 GRIP STRENGTH DECREASED 1
125 GYNAECOMASTIA 1
126 HAEMOGLOBIN DECREASED 1
127 HAEMOPTYSIS 1
128 HAEMORRHAGE URINARY TRACT 1
129 HALLUCINATION 1
130 HEART TRANSPLANT 1
131 HERPES ZOSTER 1
132 HIATUS HERNIA 1
133 HIP FRACTURE 1
134 HOSPITALISATION 1
135 HYPERHIDROSIS 1
136 HYPERSENSITIVITY 1
137 HYPERTENSION 1
138 HYPOACUSIS 1
139 HYPOAESTHESIA 1
140 HYPOGEUSIA 1
141 HYPOPHAGIA 1
142 HYPOSMIA 1
143 HYPOTENSION 1
144 IMMOBILE 1
145 IMPAIRED HEALING 1
146 IMPLANTABLE DEFIBRILLATOR INSERTION 1
147 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
148 INFECTIOUS MONONUCLEOSIS 1
149 INFLAMMATION 1
150 INFUSION SITE INFECTION 1
151 INJECTION SITE BRUISING 1
152 INTENTIONAL DOSE OMISSION 1
153 INTERVERTEBRAL DISC DEGENERATION 1
154 INTERVERTEBRAL DISC DISORDER 1
155 INTESTINAL FUNCTIONAL DISORDER 1
156 INTESTINAL OBSTRUCTION 1
157 INTRA-ABDOMINAL FLUID COLLECTION 1
158 IRON DEFICIENCY 1
159 JAUNDICE 1
160 KIDNEY INFECTION 1
161 KNEE ARTHROPLASTY 1
162 LACRIMATION INCREASED 1
163 LIP SWELLING 1
164 LOCALISED INFECTION 1
165 LOSS OF CONSCIOUSNESS 1
166 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
167 LUNG TRANSPLANT 1
168 MANIA 1
169 MEDICATION ERROR 1
170 METASTASES TO LIVER 1
171 METASTASIS 1
172 MULTIPLE SCLEROSIS 1
173 MUSCLE SPASMS 1
174 MUSCLE SPASTICITY 1
175 MUSCULOSKELETAL DISORDER 1
176 NASAL CONGESTION 1
177 NASOPHARYNGITIS 1
178 NEOPLASM 1
179 NIGHTMARE 1
180 NO ADVERSE EVENT 1
181 NON-CARDIAC CHEST PAIN 1
182 OCULAR DISCOMFORT 1
183 OESOPHAGEAL INFECTION 1
184 OROPHARYNGEAL PAIN 1
185 OROPHARYNGEAL SWELLING 1
186 OVERDOSE 1
187 PAIN OF SKIN 1
188 PALPITATIONS 1
189 PANCREATIC CYST 1
190 PARAESTHESIA 1
191 PARALYSIS 1
192 PARANOIA 1
193 PATELLA FRACTURE 1
194 PATHOLOGICAL FRACTURE 1
195 PERONEAL NERVE PALSY 1
196 PHARMACEUTICAL PRODUCT COMPLAINT 1
197 PHARYNGEAL OEDEMA 1
198 PLASMA CELL MYELOMA 1
199 POSTNASAL DRIP 1
200 PRODUCT PACKAGING QUANTITY ISSUE 1
201 PRODUCT SUBSTITUTION ISSUE 1
202 PRODUCTIVE COUGH 1
203 PROSTATE CANCER 1
204 PROSTATE INFECTION 1
205 PROSTATIC SPECIFIC ANTIGEN INCREASED 1
206 PYELONEPHRITIS 1
207 PYREXIA 1
208 QUALITY OF LIFE DECREASED 1
209 RASH PRURITIC 1
210 RECTAL DISCHARGE 1
211 RECTAL HAEMORRHAGE 1
212 RED BLOOD CELL COUNT DECREASED 1
213 RENAL CANCER 1
214 RENAL DISORDER 1
215 RHINORRHOEA 1
216 RIB FRACTURE 1
217 SCAR 1
218 SEIZURE 1
219 SENSORY DISTURBANCE 1
220 SINUS BRADYCARDIA 1
221 SKIN BURNING SENSATION 1
222 SKIN DISCOLOURATION 1
223 SKIN HYPOPIGMENTATION 1
224 SKIN IRRITATION 1
225 SLOW SPEECH 1
226 SPUTUM DISCOLOURED 1
227 STEVENS-JOHNSON SYNDROME 1
228 STREPTOCOCCAL INFECTION 1
229 SUDDEN DEATH 1
230 SUSPECTED OFF LABEL USE 1
231 TASTE DISORDER 1
232 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
233 THERAPY CESSATION 1
234 THERAPY INTERRUPTED 1
235 THERAPY PARTIAL RESPONDER 1
236 THROMBOCYTOPENIA 1
237 TOOTH DISORDER 1
238 TOXIC EPIDERMAL NECROLYSIS 1
239 TOXICITY TO VARIOUS AGENTS 1
240 UPPER RESPIRATORY TRACT INFECTION 1
241 URINARY INCONTINENCE 1
242 URINE ODOUR ABNORMAL 1
243 URTICARIA 1
244 UVEITIS 1
245 VIRAL INFECTION 1
246 WEIGHT INCREASED 1
247 WHITE BLOOD CELL COUNT 1
248 WHITE BLOOD CELL COUNT DECREASED 1
249 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1